Nasdaq · CIK 0001796280
ORIC Oric Pharmaceuticals, Inc.
Insider trading from SEC Form 4. Last filing Mar 4, 2025. Close $11.99 on Oct 9, 2026, +60% from the 52-week low and -18% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
7
with a Form 4 at this company
Price and insider trades, last year
ORICOct 9, 2026 · close 11.99
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Oric Pharmaceuticals, Inc., scored.
| Score | Side | Insider | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 37Weak | sell 3 | Jacob Chacko PRESIDENT AND CEO | $204k | 24,660 | -3% | - | |
| 28Weak | sell 3 | Pratik S Multani Chief Medical Officer | $73k | 8,850 | -16% | - | |
| 30Weak | sell 3 | Dominic Piscitelli Chief Financial Officer | $73k | 8,851 | -8% | - |
Transactions
The last 25 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | Lori Anne Kunkel director | MOption exercise Common Stock | +27,666 | $3.75 | $104k | 48,166 | Mar 4, 2025 |
| Mar 3, 2025 | Lori Anne Kunkel director | MOption exercise Common Stock | +20,500 | $6.33 | $130k | 68,666 | Mar 4, 2025 |
| Mar 3, 2025 | Lori Anne Kunkel director | MOption exercise Stock Option (right to buy)derivative | -27,666 | $0.00 | $0 | 5,534 | Mar 4, 2025 |
| Mar 3, 2025 | Lori Anne Kunkel director | MOption exercise Stock Option (right to buy)derivative | -20,500 | $0.00 | $0 | 0 | Mar 4, 2025 |
| Jan 2, 2025 | Mardi Dier director | AGrant or award Stock Option (right to buy)derivative | +35,000 | $0.00 | $0 | 35,000 | Jan 6, 2025 |
| Jan 2, 2025 | Richard A. Heyman director | AGrant or award Stock Option (right to buy)derivative | +35,000 | $0.00 | $0 | 35,000 | Jan 6, 2025 |
| Jan 2, 2025 | Steven L. Hoerter director | AGrant or award Stock Option (right to buy)derivative | +35,000 | $0.00 | $0 | 35,000 | Jan 6, 2025 |
| Jan 2, 2025 | Lori Anne Kunkel director | AGrant or award Stock Option (right to buy)derivative | +35,000 | $0.00 | $0 | 35,000 | Jan 6, 2025 |
| Jan 2, 2025 | Jacob Chacko PRESIDENT AND CEO | AGrant or award Stock Option (right to buy)derivative | +600,000 | $0.00 | $0 | 600,000 | Jan 3, 2025 |
| Jan 2, 2025 | Jacob Chacko PRESIDENT AND CEO | AGrant or award Restricted Stock Unitderivative | +100,000 | $0.00 | $0 | 100,000 | Jan 3, 2025 |
| Dec 15, 2024 | Dominic Piscitelli Chief Financial Officer | MOption exercise Common Stock | +24,042 | $0.00 | $0 | 115,615 | Dec 17, 2024 |
| Dec 15, 2024 | Pratik S Multani Chief Medical Officer | MOption exercise Common Stock | +24,042 | $0.00 | $0 | 55,615 | Dec 17, 2024 |
| Dec 15, 2024 | Jacob Chacko PRESIDENT AND CEO | MOption exercise Common Stock | +67,000 | $0.00 | $0 | 803,308 | Dec 17, 2024 |
| Dec 16, 2024 | Dominic Piscitelli Chief Financial Officer | SOpen-market sale Common Stock | -8,851 | $8.28 | $73k | 106,764 | Dec 17, 2024 |
| Dec 16, 2024 | Pratik S Multani Chief Medical Officer | SOpen-market sale Common Stock | -8,850 | $8.28 | $73k | 46,765 | Dec 17, 2024 |
| Dec 16, 2024 | Jacob Chacko PRESIDENT AND CEO | SOpen-market sale Common Stock | -24,660 | $8.28 | $204k | 778,648 | Dec 17, 2024 |
| Dec 15, 2024 | Jacob Chacko PRESIDENT AND CEO | MOption exercise Restricted Stock Unitderivative | -16,667 | $0.00 | $0 | 0 | Dec 17, 2024 |
| Dec 15, 2024 | Pratik S Multani Chief Medical Officer | MOption exercise Restricted Stock Unitderivative | -6,042 | $0.00 | $0 | 0 | Dec 17, 2024 |
| Dec 15, 2024 | Dominic Piscitelli Chief Financial Officer | MOption exercise Restricted Stock Unitderivative | -6,042 | $0.00 | $0 | 0 | Dec 17, 2024 |
| Dec 15, 2024 | Jacob Chacko PRESIDENT AND CEO | MOption exercise Restricted Stock Unitderivative | -22,000 | $0.00 | $0 | 22,000 | Dec 17, 2024 |
| Dec 15, 2024 | Pratik S Multani Chief Medical Officer | MOption exercise Restricted Stock Unitderivative | -8,000 | $0.00 | $0 | 8,000 | Dec 17, 2024 |
| Dec 15, 2024 | Dominic Piscitelli Chief Financial Officer | MOption exercise Restricted Stock Unitderivative | -8,000 | $0.00 | $0 | 8,000 | Dec 17, 2024 |
| Dec 15, 2024 | Jacob Chacko PRESIDENT AND CEO | MOption exercise Restricted Stock Unitderivative | -28,333 | $0.00 | $0 | 56,667 | Dec 17, 2024 |
| Dec 15, 2024 | Pratik S Multani Chief Medical Officer | MOption exercise Restricted Stock Unitderivative | -10,000 | $0.00 | $0 | 20,000 | Dec 17, 2024 |
| Dec 15, 2024 | Dominic Piscitelli Chief Financial Officer | MOption exercise Restricted Stock Unitderivative | -10,000 | $0.00 | $0 | 20,000 | Dec 17, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Jacob ChackoPRESIDENT AND CEO
- Mardi Dierdirector, cfo, officer
- Richard A. Heymandirector
- Steven L. Hoerterdirector
- Lori Anne Kunkeldirector
- Pratik S MultaniChief Medical Officer
- Dominic PiscitelliChief Financial Officer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.